DAVID PENCE: Open Payments
NPI 1457462970 · BEAVER FALLS, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,542 in 125 payments from 16 companies in 2025. Trend: 2023 $1,638 · 2024 $1,745 · 2025 $2,542
Food & beverage: $2,542
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 34 | $632 |
| Madrigal Pharmaceuticals | 18 | $612 |
| Janssen Biotech, Inc. | 14 | $209 |
| Celltrion USA Inc. | 11 | $179 |
| PFIZER INC. | 12 | $162 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $134 |
| Ardelyx, Inc. | 6 | $121 |
| Regeneron Healthcare Solutions, Inc. | 5 | $120 |
| Ipsen Biopharmaceuticals, Inc | 4 | $90 |
| Novo Nordisk Inc | 4 | $89 |
Products named: REZDIFFRA, RINVOQ, TREMFYA, VEGZELMA, DUPIXENT, XELJANZ, IBSRELA, CREON.
Industry payments across PA — which companies pay providers there.
